| 摘要 |
<p>The present invention provides a method of treating an aqueous-deficient dry eye state in a patient suffering therefrom, which method includes the step of administering a muramyl peptide, e.g. N-acetyl-D-glucosaminyl-(β 1-4)-acetyl muramyl-L-alanyl-D-isoglutamine (GMDP).</p> |
